The Chief Executive Officer (CEO) of the Food and Drugs Authority (FDA), Mrs. Delese Darko, has revealed that “the National Blood Service Ghana (NBSG) and the FDA has come to a formal agreement detailing how to achieve the ideal of ensuring that every unit of blood intended to be transfused is of adequate safety and quality in the interest of every patient that may need blood”.

Mrs. Darko made this revelation on Friday, 19th October, 2018, when the FDA embarked on a blood donation drive, second in the series, as part of its Corporate Social Responsibility (CSR) towards complementing the stock levels at the Southern Area Blood Center (Korle-Bu), Accra.

In a speech appealing to staff of the FDA as well as others from neighboring agencies to donate blood, Mrs. Darko, stated that “a nation’s blood supply is a unique life-saving resource” and that the gift of blood is the gift of life.

Mrs. Darko, added that “every two seconds, someone needs blood; meanwhile, there is no substitute for human blood and blood connot be manufactured”. She went further to state that “blood can only come from generous healthy donors”, as a result, “a lot of work has already been done as far as the safety, availability and assurance of blood and blood components are concerned”.

The World Health Organization (WHO) and the Ghana Health Service (GHS) have listed whole blood and its derivatives as essential medicines, indispensible and a potentially lifesaving medical intervention.

The FDA duly invited neighboring agencies like the Ghana Standards Authority (GSA), Nurses and Midwifery Council (NMC), National Identification Authority (NIA), CSIR- Food Research Institute, West Africa Examination Council (WAEC) to participate in the blood donation exercise.

The blood donation exercise, which ended successfully with 82 units of blood collected from donors, was organized with support from Nestle Ghana Limited, Guinness Ghana Limited, Fiesta Royale Hotel and GS Plaza Hotel.

Print Friendly